Patent · US Active

Quinazolinone derivatives as PARP inhibitors

US9522905B2 · kind B2 · utility

1Cited by

19References

11Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Jérôme Emile Georges Guillemont · Andé, FR
Ludo Edmond Josephine Kennis · Lier, BE
Josephus Carolus Mertens · Oud-Turnhout, BE
Jacobus Alphonsus Josephus Van Dun · Kasterlee, BE
Maria Victorina Francisca Somers · Vosselaar, BE
Walter Boudewijn Leopold Wouters · Kapellen, BE

Key dates

Filing date	Nov 12, 2013
Grant date	Dec 20, 2016
Priority date	—
Expiry date	Sep 18, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)wherein R1, R2, R3, L, X, Y and Z have defined meanings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.